Sarepta Therapeutics, Inc. · NASDAQ:SRPT
D. E. Shaw & Co., L.P.'s stake in Sarepta Therapeutics, Inc. fell to 1.90% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
D. E. Shaw & Co., L.P.'s stake in Sarepta Therapeutics, Inc. fell to 1.90%, 2,007,025 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 1.90%
- Shares
- 2,007,025
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| D. E. Shaw & Co., L.P. | 1.90% | 2,007,025 |
| David E. Shaw | 1.90% | 2,007,025 |
Source
Related
- Sarepta Therapeutics, Inc.
- D. E. Shaw & Co., L.P.
- Sarepta Therapeutics, Inc. shareholders
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 25, 2025
- Schedule 13G/A · D. E. Shaw & Co., L.P. · Jul 25, 2025
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026